Opinion|Videos|August 5, 2024

Combination Regimens with BTK Inhibitors: New Frontiers in CLL Treatment

A panel of experts discuss combination regimens with BTK inhibitors.

Video content above is prompted by the following question(s):

  1. What emerging evidence is there for combination therapies of BTK inhibitors with new and existing therapies to enhance treatment efficacy in CLL? 

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo